Inventor · disambiguated record
Yugang Liu
Also filed as: LIU YUGANG
28 granted patents·16 pending applications·112 citations·filing 2002–2024
95Inventor score
Top patents by PatentIndex Score
44 records- 0196US8877938B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2006·Granted Nov 4, 2014·44 cites·14 claims
- 0291US11932630B2Heteroaryl aminopropanol derivativesNOVARTIS AG·Filed 2022·Granted Mar 19, 2024·2 cites·20 claims
- 0391US2025339395A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2024·Application pending·0 cites
- 0488US8008263B2Organic compounds and their usesNOVARTIS AG·Filed 2008·Granted Aug 30, 2011·12 cites·17 claims
- 0586US9388134B2Compounds containing S-N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl)-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2014·Granted Jul 12, 2016·5 cites·15 claims
- 0685US8222425B2Organic compounds and their usesBRITT SHAWN D·Filed 2011·Granted Jul 17, 2012·12 cites·5 claims
- 0784US11642329B2Amorphous solid form of compounds containing S—N-valeryl-N- {[2′-( 1 H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Granted May 9, 2023·0 cites·2 claims
- 0884US8486930B2SaltsDE LA CRUZ MARILYN·Filed 2009·Granted Jul 16, 2013·8 cites·20 claims
- 0983US2022257551A1Amorphous solid form of compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2022·Application pending·0 cites
- 1081US11096918B2Amorphous solid form of compounds containing S—N-valeryl-N-{[2′-(1H-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2R,4S)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and sodium cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2019·Granted Aug 24, 2021·0 cites·2 claims
- 1181US8216671B2Luminescent glass element, producing method thereof and luminescing method thereofZHOU MINGJIE·Filed 2011·Granted Jul 10, 2012·5 cites·18 claims
- 1279US8115181B2Luminescent glass element, producing method thereof and luminescing method thereofZHOU MINGJIE·Filed 2011·Granted Feb 14, 2012·3 cites·18 claims
- 1379US2021361610A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS PHARMACEUTICALS CORP·Filed 2021·Application pending·0 cites
- 1476US8173634B2Polymorphic form of 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethyl-benzyloxyimino]-ethyl}-2-ethyl-benzyl)-azetidine-3-carboxylicLIU YUGANG·Filed 2009·Granted May 8, 2012·7 cites·7 claims
- 1575US8217370B2Luminescent glass element, producing method thereof and luminescing method thereofZHOU MINGJIE·Filed 2011·Granted Jul 10, 2012·2 cites·18 claims
- 1672US8748435B2Pyrazolo pyrimidine derivativesMILTZ WOLFGANG·Filed 2012·Granted Jun 10, 2014·5 cites·12 claims
- 1772US8697682B2SaltsDE LA CRUZ MARILYN·Filed 2013·Granted Apr 15, 2014·2 cites·20 claims
- 1872US2024199593A1Novel Heteroaryl Aminopropanol DerivativesNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1972US2019374498A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2072US2019374497A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2019·Application pending·0 cites
- 2170US10668035B2Substituted bisphenyl butanoic ester derivatives as NEP inhibitorsNOVARTIS AG·Filed 2019·Granted Jun 2, 2020·1 cites·21 claims
- 2269US2018344679A1Compounds containing s-n-valeryl-n-{[2'-(1h-tetrazole-5-yl)-biphenyl-4-yl]-methyl}-valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 2368US8217369B2Luminescent glass element, producing method thereof and luminescing method thereofZHOU MINGJIE·Filed 2011·Granted Jul 10, 2012·2 cites·18 claims
- 2466US9000667B2Luminescent element, preparation method thereof and luminescence methodZHOU MINGJIE·Filed 2009·Granted Apr 7, 2015·1 cites·10 claims
- 2564US9096799B2Luminescent element, preparation method thereof and luminescence methodZHOU MINGJIE·Filed 2009·Granted Aug 4, 2015·1 cites·9 claims
- 2662US11426375B2Substituted bisphenyl butanoic ester derivatives as NEP inhibitorsNOVARTIS AG·Filed 2020·Granted Aug 30, 2022·0 cites·26 claims
- 2762US2016324821A1Compounds containing s-n-valeryl-n--valine and (2r,4s)-5-biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid ethyl ester moieties and cationsFENG LILI·Filed 2016·Application pending·0 cites
- 2860US9101035B2Luminescent element, its preparation method thereof and luminescene methodZHOU MINGJIE·Filed 2009·Granted Aug 4, 2015·0 cites·8 claims
- 2960US8525400B2Luminescent element, preparation method thereof and luminescence methodZHOU MINGJIE·Filed 2009·Granted Sep 3, 2013·0 cites·10 claims
- 3053US9087685B2Method for raising luminous efficiency of field emissive luminescent material, luminescent glass element and the preparing method thereofZHOU MINGJIE·Filed 2009·Granted Jul 21, 2015·0 cites·12 claims
- 3152US9102874B2Luminescent element, preparation method thereof and luminescence methodZHOU MINGJIE·Filed 2009·Granted Aug 11, 2015·0 cites·9 claims
- 3252US9096796B2Luminescent element, preparation method thereof and luminescence methodZHOU MINGJIE·Filed 2009·Granted Aug 4, 2015·0 cites·9 claims
- 3350US8415017B2Luminescent glass element, producing method thereof and luminescing method thereofZHOU MINGJIE·Filed 2011·Granted Apr 9, 2013·0 cites·18 claims
- 3448US2009247581A1Organic CompoundsPRASHAD MAHAVIR·Filed 2006·Application pending·0 cites
- 3548US2008300410A1Organic CompoundsPRASHAD MAHAVIR·Filed 2006·Application pending·0 cites
- 3644US8747681B2Preparation method of fluorescent powder layerZHOU MINGJIE·Filed 2010·Granted Jun 10, 2014·0 cites·11 claims
- 3743US2012001093A1Luminescent glass element, producing method thereof and luminescing method thereofZHOU MINGJIE·Filed 2011·Application pending·0 cites
- 3841US2013209794A1Light emission apparatus and manufacturing method thereofZHOU MINGJIE·Filed 2010·Application pending·0 cites
- 3941US2012326056A1Glass substrate light emitting element and methods for manufacturing and luminescence thereofZHOU MINGJIE·Filed 2010·Application pending·0 cites
- 4040US8258128B2Organic compoundsBOLLINGER PIETRO·Filed 2007·Granted Sep 4, 2012·0 cites·15 claims
- 4140US7915264B2Fused pyridine derivatives for use as vanilloid receptor antagonists for treating painNOVARTIS AG·Filed 2002·Granted Mar 29, 2011·0 cites·6 claims
- 4240US2014021500A1Light emitting device and manufacturing method thereofZHOU MINGJIE·Filed 2010·Application pending·0 cites
- 4337US2012302756A1Process for synthesis of 2-substituted pyrrolidines and piperadinesLELETI RAJENDER REDDY·Filed 2011·Application pending·0 cites
- 4437US2012122836A1Polymorphic form of 1-(4--2-ethyl-benzyl)-azetidine-3-carboxylicLIU YUGANG·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yugang Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →